← Back to Clinical Trials
Recruiting Phase 4 NCT06406010

Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy

Trial Parameters

Condition Anesthesia, Local
Sponsor Matias Vested
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 90
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-08-19
Completion 2026-02-01
Interventions
Ropivacaine 5mg/ml 20mlSaline 0.9%

Brief Summary

The aim of this study is to determine the effect of PENG blockade on postoperative pain after either ropivacaine 5 mg/mL or saline (placebo) in patients undergoing PAO. The hypothesis of this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo (saline).

Eligibility Criteria

Inclusion Criteria: 1. Patients ≥ 18 years old 2. Informed consent 3. Scheduled for periacetabular osteotomy under general anesthesia with intubation 4. American Society of Anesthesiologists (ASA) physical status classification I to III 5. Can read and understand Danish Exclusion Criteria: 1. Known allergy to ropivacaine 2. Daily use of opioids, gabapentin or tricyclic antidepressant (regardless of dose) within the last four weeks prior to surgery 3. Contraindications to Celocoxib, NSAIDs or paracetamol

Related Trials